Larvol Delta - Beamion-LUNG2-A-Study-to-Test-Whether-Zongertinib-BI-1810631-Helps-People-With-Advanced-Nonsmall-Cell-Lung-Cancer-With-HER2-Mutations-Compared-With-Standard-Treatment

Keytruda (pembrolizumab) - Merck (MSD)

Hernexeos (zongertinib) - Boehringer Ingelheim

http://clinicaltrials.gov/ct2/show/NCT06151574

Sep 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next